Breakthroughs in Personalized Medicine for Rare Kidney Disease

View Transcript

The NEPTUNE match study builds kidney atlas. Visit Health Lab to read the full story

Transcript

Host: 

Welcome to Health Lab, your destination for news and stories about the future of healthcare. Today: Breakthroughs in personalized medicine for rare kidney disease. The NEPTUNE match study builds kidney atlas.

Researchers led by Matthias Kretzler, M.D., have achieved a significant breakthrough in the field of personalized medicine for kidney disease by building a comprehensive human kidney cell and tissue catalog. Their research lays the foundation for the development of new treatments that have the potential to greatly improve patient outcomes and quality of life.

The National Center for Advancing Translational Sciences has recognized the value and impact of this kidney atlas, as well as the NEPTUNE Match study, in advancing precision medicine for patients with rare kidney diseases. 

Kretzler is the principal investigator for the NEPTUNE Match program, which aims to match patients with the right treatment at the right time in their disease course. The program provides individualized information about their disease biology to patients and their healthcare providers. This data includes detailed clinical and genetic history, molecular profiles, and predictive biomarkers from over 850 participants in the NEPTUNE study. The goal of the study is to enhance treatment outcomes and improve the quality of life for patients. 

Through the NEPTUNE Match study, non-invasive methods enable the creation of real time individualized disease profiles for patients. These profiles are then compared with mechanisms being targeted by ongoing clinical trials to see how strongly they align. This empowers patients and providers to make more informed decisions about the suitability of participating in a specific trial. 

“NEPTUNE Match is a significant advancement in rare kidney disease research, representing a transformative step toward personalized medicine,” Kretzler said. “By providing individualized disease profiles, this program has the potential to revolutionize the management of rare kidney diseases, leading to improved treatment outcomes and enhanced quality of life for patients.”

For more on this story and for others like it, visit michiganmedicine.org/health-lab. Health Lab is a part of the Michigan Medicine Podcast Network, and is produced by the Michigan Medicine Department of Communication. You can subscribe to Health Lab wherever you listen to podcasts.